Bourque Alda L, Sullivan Mary E, Winter Michael R
Boston Medical Center, Boston, Massachusetts 02118, USA.
Gastroenterol Nurs. 2012 Sep;35(5):308-12. doi: 10.1097/SGA.0b013e3182603436.
The purpose of this study was to determine whether the use of Reiki decreases the amount of meperidine administered to patients undergoing screening colonoscopy. The literature review reveals limited studies to show whether Reiki has been able to decrease the amount of opioid the patient receives during screening colonoscopy. A chart review of 300 patients was conducted to obtain baseline average doses of meperidine patients received as the control. Following the chart review, 30 patients were recruited to the Reiki study. Twenty-five of the study arm patients received Reiki in conjunction with meperidine. Five randomly chosen study arm patients received placebo Reiki in conjunction with meperidine in an attempt to blind the clinicians to the treatment received by the patients. Results showed that there were no significant differences in meperidine administration between the patients in the chart review group (control) and the Reiki group. The study revealed that 16% who received Reiki, together with intravenous administration of conscious sedation, received less than 50 mg of meperidine. All the patients in the chart review group received more than 50 mg of meperidine. Results from this pilot study suggest that there may be a decrease in meperidine needed during screening colonoscopy when patients receive Reiki treatments before the procedure. A larger study powered to detect smaller medication differences is the next step in more accurately determining the effect of Reiki on pain management.
本研究的目的是确定使用灵气疗法是否能减少接受结肠镜筛查患者的哌替啶用量。文献综述显示,关于灵气疗法能否减少患者在结肠镜筛查期间所接受阿片类药物用量的研究有限。对300名患者的病历进行回顾,以获取患者作为对照所接受的哌替啶基线平均剂量。病历回顾之后,招募了30名患者参与灵气疗法研究。研究组中的25名患者在使用哌替啶的同时接受灵气疗法。随机选择研究组中的5名患者在使用哌替啶的同时接受安慰剂灵气疗法,以使临床医生对患者所接受的治疗不知情。结果显示,病历回顾组(对照组)患者与灵气疗法组患者在哌替啶使用量上没有显著差异。研究显示,接受灵气疗法并同时静脉注射清醒镇静剂的患者中,16%接受的哌替啶少于50毫克。病历回顾组的所有患者接受的哌替啶都超过50毫克。这项初步研究的结果表明,在结肠镜筛查前接受灵气疗法治疗的患者,在筛查期间所需的哌替啶用量可能会减少。下一步需要开展一项规模更大的研究,以检测出更小的药物差异,从而更准确地确定灵气疗法对疼痛管理的效果。